Covered populations typically separate into three distinct groups: members who initiate, stay adherent, and reach their obesity goals
If a patient does not respond to the first-line therapy (amitriptyline, cyproheptadine, and/or propranolol) the following options should be considered: (1) presence of persisting triggers (e.g., psychological stressors) and comorbid conditions (e.g., anxiety, POTS) or missed underlying disorders (e.g., hydronephrosis, chronic sinusitis, acute appendicitis, intestinal malrotation with volvulus, CNS tumors, metabolic crises) and toxic exposure (e.g., cannabis)
Digestive support supplements GLP-1 medications slow gastric emptying
Theyll evaluate your situation and decide if GLP-1 drugs are a good fit
Standardized records should include drug type, dosage, duration, interval between discontinuation and conception, and concomitant medications or contraceptive methods